Greenspace Health secures Series B funding from ABS Capital Partners to advance its Measurement-Based Care technology and transform behavioral healthcare delivery.

Target Information

Greenspace Health is a leading provider of Measurement-Based Care (MBC) technology, operating within the software as a service (SaaS) sector. The company has successfully implemented its platform in over 500 locations, completing more than 5 million assessments across various healthcare settings, including clinics, hospitals, and community organizations. Greenspace aims to enhance the clinical outcomes and care quality in behavioral healthcare through data-driven insights and operational efficiencies.

By empowering behavioral health providers with measurement tools, Greenspace facilitates the transition to value-based care, ensuring that both patients and providers benefit from enhanced engagement and improved outcomes. The significance of Greenspace’s innovative solutions lies in their ability to transform behavioral healthcare dynamics, making them a vital player in this evolving landscape.

Industry Overview in the United States

The behavioral healthcare industry in the United States is undergoing a significant transformation as the demand for high-quality, outcomes-driven care continues to rise. Traditional models of care are being replaced by value-based care frameworks that prior

View Source

Similar Deals

ARCH Venture Partners, GV (Google Ventures) Pelage Pharmaceuticals

2025

Series B Proprietary & Advanced Pharmaceuticals United States of America
Goldman Sachs Alternatives evolvedMD

2025

Series B Hospitals, Clinics & Primary Care Services United States of America
EQT Life Sciences, Sanofi Ventures SpliceBio

2025

Series B Bio Therapeutic Drugs United States of America
Accelmed Partners Acclaro Medical

2025

Series B Laser Equipment United States of America
Blue Owl Capital Latigo Biotherapeutics

2025

Series B Bio Therapeutic Drugs United States of America
Ysios Capital Neurona Therapeutics

2025

Series B Bio Therapeutic Drugs United States of America

ABS Capital Partners

invested in

Greenspace Health

in 2025

in a Series B deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert